Benkowitz Michael's Form 4 filing
United Therapeutics Corp (UTHR) · filed Jan 28, 2026
- Accession no.
- 0001673232-26-000006
- Filed
- Jan 28, 2026
- Trade date
- Jan 20, 2026
- Filing delay
- 8 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 15 non-derivative transactions and 1 derivative transaction. Open-market sales total $6.80M. It was filed 8 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Benkowitz MichaelCIK 0001673232 | Officer (PRESIDENT AND COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | Common Stock | MOption exerciseDisposed | −14,625 | $117.76 | −$1,722,240 | 14,625 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −116 | $456.87 | −$52,996.92 | 14,509 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −692 | $457.92 | −$316,880.64 | 13,817 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −700 | $458.74 | −$321,118 | 13,117 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −498 | $459.87 | −$229,015.26 | 12,619 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −503 | $461.12 | −$231,943.36 | 12,116 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −2,456 | $463.26 | −$1,137,766.56 | 9,660 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −2,274 | $464.06 | −$1,055,272.44 | 7,386 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −1,794 | $465.11 | −$834,407.34 | 5,592 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −1,055 | $466.06 | −$491,693.3 | 4,537 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −596 | $467.09 | −$278,385.64 | 3,941 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −2,922 | $468.12 | −$1,367,846.64 | 1,019 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −837 | $469.18 | −$392,703.66 | 182 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −156 | $470.37 | −$73,377.72 | 26 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −26 | $470.76 | −$12,239.76 | 0 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | Common Stock | MOption exerciseDisposed | −14,625 | $0.00 | $0 | 67,875 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.